ES2097162T3 - Utilizacion de acidos grasos de cadena corta en alimentacion clinica. - Google Patents

Utilizacion de acidos grasos de cadena corta en alimentacion clinica.

Info

Publication number
ES2097162T3
ES2097162T3 ES91105502T ES91105502T ES2097162T3 ES 2097162 T3 ES2097162 T3 ES 2097162T3 ES 91105502 T ES91105502 T ES 91105502T ES 91105502 T ES91105502 T ES 91105502T ES 2097162 T3 ES2097162 T3 ES 2097162T3
Authority
ES
Spain
Prior art keywords
chain fatty
short chain
fatty acids
coo
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91105502T
Other languages
English (en)
Inventor
Richard Cotter
Hugh Tucker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24016582&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2097162(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter International Inc filed Critical Baxter International Inc
Application granted granted Critical
Publication of ES2097162T3 publication Critical patent/ES2097162T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

USO DE ACIDOS GRASOS DE CADENA CORTA PARA LA PREPARACION DE UN MEDICAMENTO PARA MANTENER LA INTEGRIDAD Y FUNCION GASTROINTESTINAL EN CONDICIONES DONDE LOS SUSTRATOS DE ACIDO GRASO DE CADENA CORTA, PROPORCIONADOS POR LA FERMENTACION BACTERIAL DE CARBOHIDRATOS, SON INADECUADOS DEBIDO A LA CONDICION CLINICA DEL PACIENTE. LOS MEDICAMENTOS PUEDEN SER PROPORCIONADOS BIEN EN PREPARADOS ENTERALES O EN PREPARADOS PARENTALES. LOS ACIDOS GRASOS DE CADENA CORTA PUEDEN OBTENERSE POR LA HIDROLISIS DE UNA ESTRUCTURA COMO: EN DONDE R-COO-, R''-COO-, Y R"-COOTAN BIEN LOS MISMOS RESIDUOS DE ACIDO GRASO DE CADENA CORTA O DIFERENTES.
ES91105502T 1990-04-10 1991-04-08 Utilizacion de acidos grasos de cadena corta en alimentacion clinica. Expired - Lifetime ES2097162T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50693890A 1990-04-10 1990-04-10

Publications (1)

Publication Number Publication Date
ES2097162T3 true ES2097162T3 (es) 1997-04-01

Family

ID=24016582

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91105502T Expired - Lifetime ES2097162T3 (es) 1990-04-10 1991-04-08 Utilizacion de acidos grasos de cadena corta en alimentacion clinica.

Country Status (8)

Country Link
US (1) US5919822A (es)
EP (1) EP0451750B1 (es)
JP (1) JPH05306222A (es)
AT (1) ATE145554T1 (es)
AU (1) AU645070B2 (es)
CA (1) CA2039980A1 (es)
DE (1) DE69123278T2 (es)
ES (1) ES2097162T3 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262555B1 (en) 1998-10-02 2001-07-17 Robicon Corporation Apparatus and method to generate braking torque in an AC drive
AU773195B2 (en) * 1999-07-01 2004-05-20 Commonwealth Scientific And Industrial Research Organisation Nasogastric enteral formulations
AUPQ132599A0 (en) * 1999-07-01 1999-07-22 Commonwealth Scientific And Industrial Research Organisation Nasogastric enteral formulations
AUPQ851000A0 (en) * 2000-06-30 2000-07-27 Commonwealth Scientific And Industrial Research Organisation Rapid fatty acid delivery
US6387952B1 (en) * 2000-09-19 2002-05-14 Arco Chemical Technology L.P. Method of treating gastrointestinal disorders, particularly colitis
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
WO2002069964A1 (en) * 2001-03-05 2002-09-12 Ernest Stephen P Enteral formulation
ITMI20040187A1 (it) * 2004-02-06 2004-05-06 Cosmo Spa Composizioni farmaceutiche o dietetiche a base di acidi grassi a catena corta e zuccheri complessi per le disfunzioni intestinali
EP1719543A1 (en) * 2005-05-04 2006-11-08 Asan Labs., Ltd. Use of histone deacetylase inhibitors for the treatment of gastrointestinal distress
JP6783247B2 (ja) 2015-01-23 2020-11-11 テンプル ユニヴァーシティ − オブ ザ コモンウェルス システム オブ ハイアー エデュケーション ガン予防における短鎖脂肪酸の使用
WO2018052357A1 (en) * 2016-09-19 2018-03-22 Perstorp Ab A dietary supplement for alleviating chronic inflammation in colon
US11065217B2 (en) 2017-01-27 2021-07-20 Temple University—Of the Commonwealth System of Higher Education Use of short chain fatty acids for the treatment and prevention of diseases and disorders
CN110891982B (zh) 2017-04-17 2023-12-22 芝加哥大学 向肠道递送短链脂肪酸以用于人体保健和疾病治疗的聚合物材料
JP2020120603A (ja) * 2019-01-30 2020-08-13 株式会社明治 ケトン体産生促進用組成物
US11666548B2 (en) 2020-06-05 2023-06-06 Baxter International Inc. Parenteral nutrition formulation
US20220160669A1 (en) 2020-11-24 2022-05-26 Baxter International Inc. Parenteral nutrition formulation

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409239A (en) * 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
DE3368377D1 (en) * 1982-04-16 1987-01-29 Nestle Sa Lipid composition for oral, enteral or parenteral feeding
US4528197A (en) * 1983-01-26 1985-07-09 Kabivitrum Ab Controlled triglyceride nutrition for hypercatabolic mammals
US4665057A (en) * 1983-03-22 1987-05-12 Deanna Nelson Nutrient monoesters
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4678807A (en) * 1984-03-01 1987-07-07 Baxter Travenol Laboratories, Inc. Method for directed visceral metabolism of medium chain triglycerides
US4721716A (en) * 1984-08-06 1988-01-26 Neesby Torben E Method for desensitizing the gastrointestinal tract from food allergies
US4585764A (en) * 1985-04-22 1986-04-29 Sterling Drug Inc. Gastric cytoprotection with 3,3'-thiobis[propanoic acid] in oral administration of aspirin
US4735967A (en) * 1985-05-28 1988-04-05 Neesby Torben E Method for desensitizing the gastrointestinal tract from food allergies
US4690820A (en) * 1985-06-07 1987-09-01 The State University Of New York High-caloric, high-fat dietary formula
US4753963A (en) * 1985-09-26 1988-06-28 The Procter & Gamble Company Nutritional fat suitable for enteral and parenteral products
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US4810726A (en) * 1987-04-01 1989-03-07 New England Deaconess Hospital Corporation Kernel oils and disease treatment
US4952606A (en) * 1988-04-05 1990-08-28 New England Deaconess Hospital Corporation Structured lipid containing dairy fat
SE8803141L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Naeringsmedel foer maenniskor och djur
US4992292A (en) * 1989-02-16 1991-02-12 Nabisco Brands, Inc. Tris-hydroxymethyl alkane dicarboxylate extended esters as low calorie fat mimetics
JPH04506084A (ja) * 1989-04-07 1992-10-22 ニュー　イングランド　ディーコネス　ホスピタル　コーポレイション 短鎖トリグリセリド
DK657689D0 (da) * 1989-12-22 1989-12-22 Novo Nordisk As Middel med biologisk virkning paa tarmslimhinden

Also Published As

Publication number Publication date
EP0451750A2 (en) 1991-10-16
EP0451750A3 (en) 1992-05-20
CA2039980A1 (en) 1991-10-11
DE69123278T2 (de) 1997-03-20
JPH05306222A (ja) 1993-11-19
ATE145554T1 (de) 1996-12-15
EP0451750B1 (en) 1996-11-27
AU645070B2 (en) 1994-01-06
DE69123278D1 (de) 1997-01-09
US5919822A (en) 1999-07-06
AU7405091A (en) 1991-10-17

Similar Documents

Publication Publication Date Title
ES2097162T3 (es) Utilizacion de acidos grasos de cadena corta en alimentacion clinica.
AU653026B2 (en) Physiologically active polypeptide-containing pharmaceutical composition
AU586286B2 (en) Pharmaceutical and dietary composition
PT1233969E (pt) Derivados mono- e dissacáridos
IE882366L (en) Immunostimulant tripeptides
CA2072366A1 (en) Carboxylic acid-metal ion-acid complexes
WO1987004926A3 (en) Method of modifying the lipid structure of cell membranes and pharmaceutical compositions for use therein
GR3004253T3 (es)
HK109395A (en) Pharmaceutical uses of fatty acids
PT84580A (en) Process for the preparation of pharmaceutical compositions containing indomethacin
JPS649938A (en) Oral ingestive composition
CA2070169A1 (en) Compounds with a sequence of three radicals, the central one being -aminoacidic and therapeutical applications thereof
JPS57139015A (en) Remedy for infectious disease for oral administration
MX9605829A (es) Inhibicion de la union del h. influenzae a celulas humanas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 451750

Country of ref document: ES